US4391909A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Microcapsules containing viable tissue cells
Assignee: Abbott Biotech Inc
•
Filing: 1981-05-01
•
Granted: 1983-07-05
•
Expires: 2001-05-01
Abstract
Abstract Tissue cells such as islet of Langerhans cells or liver cells are encapsulated within a spheroidal semipermeable membrane comprising a polysaccharide having acidic groups cross-linked with a polymer having a molecular weight greater than 3,000. The cells within the microcapsules are viable, healthy, physiologically active and capable of ongoing metabolism. The encapsulated cells are useful for implantation in a mammalian body to produce substances and effect chemical changes characteristic of the cells in vivo tissue.
Inventors
- 👤 Franklin Lim
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 10:14
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/12; A61K35/37; A61K35/407; A61F; A61F2/00; A61F2/02; A61F2/022; A61K35/39; A61K39/00; A61K39/395; A61K39/44; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1652; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5031; A61K9/5036; A61K9/5073; B; B01; B01J; B01J13/00; B01J13/02; B01J13/06; B01J13/08; B01J13/14; B01J13/16; C; C12; C12N; C12N11/00; C12N11/02; C12N11/04; C12N5/00; C12N5/0012; C12N5/06; C12N5/0602; C12N5/067; C12N5/0671; C12N5/0676; C12N5/0677; C12N2533/00; C12N2533/30; C12N2533/32; C12N2533/70; C12N2533/74
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
119 words
An insulin producing system comprising one or more viable, healthy, physiologically active mammalian islet of Langerhans tissue cells encapsulated within a spheroidal semipermeable membrane comprising a polysaccharide having acidic groups thereof cross-linked with a polymer having a molecular weight greater than 3,000, said membrane being permeable to insulin produced by the cells of said islet and substances of lower molecular weight, but impermeable to molecules having a molecular weight in excess of about 100,000 daltons and to bacteria, said spheroidal membrane further containing an aqueous medium of nutrients sufficient to maintain cells of the islet and to supply the amino acids necessary to synthesize insulin, the cells of said islet being viable, physiologically active, and capable of ongoing metabolism.
Claim 2
Dependent Claim
119 words
An insulin producing system comprising one or more viable, healthy, physiologically active mammalian islet of Langerhans tissue cells encapsulated within a spheroidal semipermeable membrane comprising a polysaccharide having acidic groups thereof cross-linked with a polymer having a molecular weight greater than 3,000, said membrane being permeable to insulin produced by the cells of said islet and substances of lower molecular weight, but impermeable to molecules having a molecular weight in excess of about 100,000 daltons and to bacteria, said spheroidal membrane further containing an aqueous medium of nutrients sufficient to maintain cells of the islet and to supply the amino acids necessary to synthesize insulin, the cells of said islet being viable, physiologically active, and capable of ongoing metabolism.
Claim 3
Dependent Claim
12 words
The system of claim 1 suspended in an islet maintaining culture medium.
Claim 4
Dependent Claim
11 words
The system of claim 2 wherein the polysaccharide is a gum.
Claim 5
Dependent Claim
99 words
A body fluid detoxifying system comprising one or more viable, healthy, physiologically active mammalian liver tissue cells encapsulated within a spheroidal membrane having a semipermeable membrane comprising a polysaccharide having acidic groups thereof cross-linked with a polymer having a molecular weight greater than 3,000, said microcapsule being permeable to blood toxins and hepatocyte maintaining nutrients but impermeable to serum immunoglobulins, lymphocytes, and bacteria, and spheroidal membrane further containing an aqueous medium of nutrients sufficient to maintain said tissue and to allow its normal metabolism, the cells of said liver tissue being viable, physiologically active, and capable of ongoing metabolism.
Claim 6
Dependent Claim
99 words
A body fluid detoxifying system comprising one or more viable, healthy, physiologically active mammalian liver tissue cells encapsulated within a spheroidal membrane having a semipermeable membrane comprising a polysaccharide having acidic groups thereof cross-linked with a polymer having a molecular weight greater than 3,000, said microcapsule being permeable to blood toxins and hepatocyte maintaining nutrients but impermeable to serum immunoglobulins, lymphocytes, and bacteria, and spheroidal membrane further containing an aqueous medium of nutrients sufficient to maintain said tissue and to allow its normal metabolism, the cells of said liver tissue being viable, physiologically active, and capable of ongoing metabolism.
Claim 7
Dependent Claim
74 words
An artificial organ suitable for implantation in a mammalian body comprising a microcapsule comprising a polysaccharide having acidic groups thereof cross-linked with a polymer having a molecular weight greater than 3,000, said membrane being no greater than about 2.0 mm in diameter and containing one or more viable, healthy, physiologically active living tissue cells, said microcapsule being impermeable to immune system proteins but permeable to tissue nutrients and metabolic products produced by the tissue.
Claim 8
Dependent Claim
74 words
An artificial organ suitable for implantation in a mammalian body comprising a microcapsule comprising a polysaccharide having acidic groups thereof cross-linked with a polymer having a molecular weight greater than 3,000, said membrane being no greater than about 2.0 mm in diameter and containing one or more viable, healthy, physiologically active living tissue cells, said microcapsule being impermeable to immune system proteins but permeable to tissue nutrients and metabolic products produced by the tissue.
Claim 9
Dependent Claim
13 words
The artificial organ of claim 5 wherein said tissue comprises pancreatic endocrine cells.
Claim 10
Dependent Claim
98 words
A tissue implantation method comprising the steps of: (a) encapsulating one or more living tissue cells within a microcapsule having a semipermeable membrane comprising a polysaccharide having acidic groups thereof cross-linked with a polymer having a molecular weight greater than 3,000, said membrane being impermeable to immune system proteins but permeable to tissue nutrients and metabolic products produced by the tissue, said microcapsule being no greater than about 2 mm in diameter, said tissue cells within said microcapsule being viable, healthy, physiologically active tissue cells capable of ongoing metabolism; and (b) introducing said microcapsule into a mammalian body.
Claim 11
Dependent Claim
98 words
A tissue implantation method comprising the steps of: (a) encapsulating one or more living tissue cells within a microcapsule having a semipermeable membrane comprising a polysaccharide having acidic groups thereof cross-linked with a polymer having a molecular weight greater than 3,000, said membrane being impermeable to immune system proteins but permeable to tissue nutrients and metabolic products produced by the tissue, said microcapsule being no greater than about 2 mm in diameter, said tissue cells within said microcapsule being viable, healthy, physiologically active tissue cells capable of ongoing metabolism; and (b) introducing said microcapsule into a mammalian body.
Claim 12
Dependent Claim
12 words
The method of claim 7 wherein the microcapsule is introduced by injection.
Claim 13
Dependent Claim
26 words
The method of claim 7 wherein the tissue cells comprise living cells selected from the group consisting of pancreatic beta cells, alpha cells, and mixtures thereof.
Claim 14
Dependent Claim
13 words
The method of claim 7 wherein the tissue cells comprise Islets of Langerhans.
Claim 15
Dependent Claim
32 words
The method of claim 7 wherein the polymer having a molecular weight greater than 3,000 is a polymer which results in the microcapsule membrane being not readily injested by said mammalian body.
Claim 16
Dependent Claim
21 words
The method of claim 8 comprising the further step of repeating said injection to provide fresh tissue cells in said body.
References Cited (Backward Citations)
FR1600988A
Cited
US3522346A
Cited
US3827565A
Cited
US3733205A
Cited
US3725113A
Cited
US3730841A
Cited
US3860490A
Cited
US4138292A
Cited
US4251387A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-07-04 | 1987-01-03 | 1987-07-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-07-04 | 1991-01-03 | 1991-07-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-07-04 | 1995-01-03 | 1995-07-05 | $7700.00 | Window Closed / Lapsed |